Displaying 1 - 20 news posts of 131
In pursuit of brain resilience
In this research roundup, we look back on some of the ways Knight Initiative scientists have been pursuing ways to keep our minds sharp well into old age
The FDA's psychedelic sea-change: what it means for mental health and neuroscience research
We talk with neuroscientist Boris Heifets about the new federal push to accelerate research on psychedelic drugs for mental health treatment
NeuroTech alumnus AJ Phillips wins second annual Three Minute Thesis competition
Three PhD candidates took top honors at this year’s event, translating years of research into presentations everyone in the room could understand.
6 Common Medications That May Lower Your Dementia Risk
Shingles vaccines appear to have a protective benefit, Knight Initiative researcher Pascal Geldsetzer has shown.
Could Parkinson's start in the gut?
We talk with neurologist Kathleen Poston about early signs of Parkinson's outside the brain and how they might influence treatment and detection
New ideas in aging and resilience research launched by Rosenkranz Foundation and Knight Initiative
The Rosenkranz Aging and Rejuvenation Seed Grant Program announced eight innovative new research projects with additional support from the Knight Initiative for Brain Resilience
Wu Tsai Neuro and Knight Initiative researchers awarded MIND Prizes
The Maximizing Innovation in Neuroscience Discovery Prizes will give Faculty Scholar Guosong Hong and Knight Initiative-supported researcher Pascal Geldsetzer $750,000 each over three years to develop research on neurodegenerative diseases.
A better Alzheimer's drug?
Frank Longo's long trek nears its destination
Reading-specific region differs in the dyslexic brain
A brain region specialized for recognizing text is smaller or absent in kids with dyslexia, but tutoring partly closes the gap
Preventing Parkinson’s, a new Alzheimer’s drug, and more featured at tenth Knight Initiative Symposium
Researchers from around the world convened at Stanford to present their latest work on neurodegeneration and brain resilience
Past, present and future perspectives on the science of aging
Knight Initiative Director Tony Wyss-Coray and others talked to Nature Aging about aging research
Big Ideas in Neuroscience tackle brain science of everyday life and more
From studying post-viral fatigue to engineering transparent mouse brains, round three of the Wu Tsai Neurosciences Institute’s Big Ideas grants will push the bounds of what’s possible
Brain organoids are helping researchers, but their use also creates unease
A recent meeting gathered scientists, ethicists, patient advocates and more to discuss organoid ethics.
Experts met to discuss the ethics of using organoids in research
Organoids are bits of neural tissue that model human brain development. Their use in science makes some uneasy, in part because the brain is so closely tied to our sense of self.
Is Alzheimer's an energy crisis in the brain?
We speak with neurologist Katrin Andreasson about new links between inflammation, metabolism and new hopes for treating neurodegeneration
2025 neuroscience research in review
Join us as we look back on some of the key studies we covered here at Wu Tsai Neuro and the Knight Initiative in 2025 to give a (very partial) overview of the impact of our community’s research efforts this past year
New Stanford center bridges neuroscience and data science to decode the brain
Stanford Data Science and the Wu Tsai Neurosciences Institute launched the Center for Neural Data Science as a collaborative hub to accelerate discovery in neuroscience and train the next generation of data-driven neuroscientists
Neuroscientists dive into the gut
The 12th annual Wu Tsai Neurosciences Institute Symposium explored how our brains and bodies communicate—and what that means for our health and well-being
Shingles vaccine may actually slow progression of dementia, study shows
If the results are confirmed, an expert said, the Knight Initiative-funded research "would be groundbreaking for dementia"
Shingles vaccine may slow progression of dementia, new study suggests
A new study from Knight Initiative researchers suggests that the two-dose shingles shot also may slow the progression of dementia